Cardiovascular Disease

AHA: Limited Benefit for n-3 Fatty Acids in CVD, Cancer Prevention

AHA: Limited Benefit for n-3 Fatty Acids in CVD, Cancer Prevention

Second study shows no significant results for vitamin D supplementation vs placebo.

AHA/ACC Release Updated Guidelines for Cholesterol Management

AHA/ACC Release Updated Guidelines for Cholesterol Management

Updated cholesterol guidelines offer more personalized cardiovascular disease risk assessment.

Does Antihypertensive Therapy Reduce CVD Risk in Low-Risk Patients With Mild Hypertension?

Does Antihypertensive Therapy Reduce CVD Risk in Low-Risk Patients With Mild Hypertension?

Treatment of low-risk patients presenting with mild hypertension with antihypertensive medication should be done with caution.

Type 2 Diabetes May Have Adverse Effect on Parkinson Disease Symptoms, Outcomes

Type 2 Diabetes May Have Adverse Effect on Parkinson Disease Symptoms, Outcomes

Patients with both Parkinson disease and type 2 diabetes were more likely to have cardiovascular comorbidities than those with only Parkinson disease.

ACC/AHA/HRS Release Updated Bradycardia Diagnosis and Management Guidelines

ACC/AHA/HRS Release Updated Bradycardia Diagnosis and Management Guidelines

By

The American College of Cardiology, the American Heart Association, and the Heart Rhythm Society have released a guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay.

Some Weather Conditions Linked to Myocardial Infarction Risk

Some Weather Conditions Linked to Myocardial Infarction Risk

Certain weather conditions are associated with an increased risk for myocardial infarction.

Disagreements in Blood Pressure Guidelines Lead to Physician, Patient Confusion

Disagreements in Blood Pressure Guidelines Lead to Physician, Patient Confusion

Discord among international, organizational blood pressure guidelines have led to confusion between physicians and patients alike.

Tibia Lead Levels Linked to Risk of Resistant-Hypertension

Tibia Lead Levels Linked to Risk of Resistant-Hypertension

Tibia lead levels are associated with resistant-hypertension.

Severity of Metabolic Syndrome Indicates Risk for T2D, CVD in Prediabetes Treatment

Severity of Metabolic Syndrome Indicates Risk for T2D, CVD in Prediabetes Treatment

Researchers analyzed how improvements in metabolic syndrome may impact the risk of developing type 2 diabetes and cardiovascular disease in patients with prediabetes.

Aspirin, Anticoagulants Similarly Prevent VTE After TKA

Aspirin, Anticoagulants Similarly Prevent VTE After TKA

Among patients undergoing total knee arthroplasty, aspirin alone may provide protection against postoperative venous thromboembolism that is similar to that of other anticoagulants.

Harvard: Heart Researcher's Papers Contain Fraudulent Data

Harvard: Heart Researcher's Papers Contain Fraudulent Data

31 scientific publications from the laboratory of Piero Anversa contain falsified and/or fabricated data.

Wall Thickness Measured by MRI More Consistently Linked to CVD

Wall Thickness Measured by MRI More Consistently Linked to CVD

Common carotid artery wall thickness measured using magnetic resonance imaging is more consistently associated with incident cardiovascular disease outcomes than intima-media thickness measured by ultrasound.

Empagliflozin Impact on Life Expectancy Examined in T2DM Patients With CVD

Empagliflozin Impact on Life Expectancy Examined in T2DM Patients With CVD

By

For this analysis, the authors used follow-up data from all 7020 patients included in the EMPA-REG OUTCOME trial to estimate the effect of empagliflozin on all-cause mortality vs placebo over the duration of a patient's lifetime.

Updated Hypertension Guideline Directs Treatment to Those With High CVD Risk

Updated Hypertension Guideline Directs Treatment to Those With High CVD Risk

Implementing ACC/AHA guideline would direct antihypertensive meds to adults at high CVD risk.

Family History Linked to Early-Onset A-Fib in Minorities

Family History Linked to Early-Onset A-Fib in Minorities

Probands of African or Hispanic/Latino descent with early-onset atrial fibrillation are more likely than European Americans to have a first-degree relative with AF.

Diabetes Common in Patients With Ischemic, Hemorrhagic Stroke

Diabetes Common in Patients With Ischemic, Hemorrhagic Stroke

By

Approximately 28% of stroke patients have diabetes, and the presence of diabetes can increase the risk for poor stroke outcome.

Southern Dietary Pattern Mediates Racial Difference in Hypertension

Southern Dietary Pattern Mediates Racial Difference in Hypertension

For both men and women, Southern dietary pattern is largest mediating factor for difference in hypertension.

Risk of Venous Thromboembolism Recurrence High

Risk of Venous Thromboembolism Recurrence High

At 6 months, rates for provoked, unprovoked, cancer-related VTE are 6.8, 6.92, 9.06 per 100 person-years.

Policies Should Encourage Healthy Food Consumption

Policies Should Encourage Healthy Food Consumption

Aim should be to prevent CVD with environment where healthy foods are accessible, desirable.

Lorcaserin Facilitates Weight Loss in Overweight, Obese

Lorcaserin Facilitates Weight Loss in Overweight, Obese

Increased weight loss vs placebo with no rise in rate of extended major cardiovascular events.

Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population

Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population

South Asians exhibit the highest rates of ASCVD among all ethnic groups, and the highest prevalence is in younger age groups; up to 25% of myocardial infarctions in India occur in individuals younger than 40 years of age.

No Clear Benefit for Rivaroxaban After Hospital Discharge

No Clear Benefit for Rivaroxaban After Hospital Discharge

Incidence of major bleeding low with rivaroxaban, but clot risk not lower.

Including Hypertensive Disorders of Pregnancy in CVD Risk Score Does Not Improve CVD Risk Prediction

Including Hypertensive Disorders of Pregnancy in CVD Risk Score Does Not Improve CVD Risk Prediction

By

Adding history of hypertensive disorders of pregnancy to the current cardiovascular disease (CVD) risk score does not improve CVD prediction in low-risk women.

Intensive Blood Pressure Therapy Lowers Cardiovascular Risk in Diabetes

Intensive Blood Pressure Therapy Lowers Cardiovascular Risk in Diabetes

Intensive blood pressure therapy is associated with a significantly lower risk for serious cardiovascular events in the adults with diabetes.

Increased Dairy Consumption Linked to Reduced CVD, Mortality Risk in Low-, Middle-Income Countries

Increased Dairy Consumption Linked to Reduced CVD, Mortality Risk in Low-, Middle-Income Countries

By

The consumption of whole-fat dairy products may reduce cardiovascular disease and mortality risk, contrary to current dietary guidelines that advise limited consumption of fat-free or low-fat dairy products.

New Guidelines Target Pharmacological Hypertension Management to High-Risk Patients

New Guidelines Target Pharmacological Hypertension Management to High-Risk Patients

A guideline-based approach directing pharmacological treatment to adults more likely to have CVD events may maximize absolute risk reduction of treatment.

Excess Cardiac Risk Varies With Age of Onset of T1D

Excess Cardiac Risk Varies With Age of Onset of T1D

Excess risk differed by up to 5 times across different diagnosis age groups.

Assessing the Evidence of Aspirin for Primary Prevention in Diabetes

Assessing the Evidence of Aspirin for Primary Prevention in Diabetes

The substantial burden of cardiovascular disease in patients with diabetes has led to the exploration of various cardiovascular disease prevention strategies, including the use of aspirin.

High LDL in Young, Healthy Adults Leaves Them Vulnerable to CVD

High LDL in Young, Healthy Adults Leaves Them Vulnerable to CVD

Findings may have implications for future cholesterol treatment paradigms.

Lower Long-Term Survival for In-Hospital Cardiac Arrests in Blacks

Lower Long-Term Survival for In-Hospital Cardiac Arrests in Blacks

Black survivors of in-hospital cardiac arrest have lower survival at 1, 3, 5 years vs whites.

Sign Up for Free e-newsletters